ABC drug transporters and immunity: Novel therapeutic targets in autoimmunity and cancer

Journal of Leukocyte Biology

Volumn 86, Issue 5, 2009, Pages 1075-1087

  Van De Ven, Rieneke ^a   Oerlemans, Ruud ^a   Van Der Heijden, Joost W ^a   Scheffer, George L ^a   De Gruijl, Tanja D ^a   Jansen, Gerrit ^a   Scheper, Rik J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ANTINEOPLASTIC AGENT; BREAST CANCER RESISTANCE PROTEIN; CHLOROQUINE; CISPLATIN; DAUNORUBICIN; DOCETAXEL; DOXORUBICIN; ELACRIDAR; EPIRUBICIN; ETOPOSIDE; GLUCOCORTICOID; IRINOTECAN; KO 143; MERCAPTOPURINE; METHOTREXATE; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3; MULTIDRUG RESISTANCE PROTEIN 4; MULTIDRUG RESISTANCE PROTEIN 5; MULTIDRUG RESISTANCE PROTEIN 6; MULTIDRUG RESISTANCE PROTEIN 7; MULTIDRUG RESISTANCE PROTEIN 8; MULTIDRUG RESISTANCE PROTEIN 9; PACLITAXEL; PZ 39; TOPOTECAN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALSPODAR; VERLUKAST; VINBLASTINE; VINCRISTINE; ZIDOVUDINE; ZOSUQUIDAR;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL MATURATION; CELL MIGRATION; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE ACTIVITY; DRUG DISTRIBUTION; DRUG TRANSPORT; EFFECTOR CELL; ENZYME SPECIFICITY; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; IMMUNOTHERAPY; INFLAMMATION; KNOCKOUT MOUSE; MULTIDRUG RESISTANCE; NATURAL KILLER CELL; NEOPLASM; NONHUMAN; ONCOLOGY; PRIORITY JOURNAL; REVIEW; TISSUE DISTRIBUTION;

ANTINEOPLASTIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; DRUG RESISTANCE, NEOPLASM; HUMANS; IMMUNITY; IMMUNOTHERAPY; NEOPLASMS;

EID: 70350733785     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0309147     Document Type: Review

References (180)

1. Borst, P., Elferink, R. O. (2002) Mammalian ABC transporters in health and disease. Annu. Rev. Biochem. 71, 537-592. (Pubitemid 34800230)
2. Eilers, M., Roy, U., Mondal, D. (2008) MRP (ABCC) transporters-mediated efflux of anti-HIV drugs, saquinavir and zidovudine, from human endothelial cells. Exp. Biol. Med. (Maywood) 233, 1149-1160.
3. Jansen, G., Scheper, R. J., Dijkmans, B. A. (2003) Multidrug resistance proteins in rheumatoid arthritis, role in disease-modifying antirheumatic drug efficacy and inflammatory processes: an overview. Scand. J. Rheumatol. 32, 325-336. (Pubitemid 38177788)
4. Sarkadi, B., Homolya, L., Szakacs, G., Varadi, A. (2006) Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system. Physiol. Rev. 86, 1179-1236. (Pubitemid 44521651)
5. Gottesman, M. M., Ambudkar, S. V. (2001) Overview: ABC transporters and human disease. J. Bioenerg. Biomembr. 33, 453-458.
6. Aye, I. L., Singh, A. T., Keelan, J. A. (2009) Transport of lipids by ABC proteins: interactions and implications for cellular toxicity, viability and function. Chem. Biol. Interact. 180, 327-339.
7. Deeley, R. G., Westlake, C., Cole, S. P. (2006) Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. Physiol. Rev. 86, 849-899. (Pubitemid 44033384)
8. Dean, M., Annilo, T. (2005) Evolution of the ATP-binding cassette (ABC) transporter superfamily in vertebrates. Annu. Rev. Genomics Hum. Genet. 6, 123-142. (Pubitemid 41397078)
9. Gillet, J. P., Efferth, T., Remacle, J. (2007) Chemotherapy-induced resistance by ATP-binding cassette transporter genes. Biochim. Biophys. Acta 1775, 237-262. (Pubitemid 46899341)
10. Kock, K., Grube, M., Jedlitschky, G., Oevermann, L., Siegmund, W., Ritter, C. A., Kroemer, H. K. (2007) Expression of adenosine triphosphate-binding cassette (ABC) drug transporters in peripheral blood cells: relevance for physiology and pharmacotherapy. Clin. Pharmacokinet. 46, 449-470. (Pubitemid 46827856)
11. Zhou, S. F., Wang, L. L., Di, Y. M., Xue, C. C., Duan, W., Li, C. G., Li, Y. (2008) Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development. Curr. Med. Chem. 15, 1981-2039.
12. Borst, P., de Wolf, C., van de Wetering, K. (2007) Multidrug resistance-associated proteins 3, 4, and 5. Pflugers Arch. 453, 661-673.
13. Kruh, G. D., Guo, Y., Hopper-Borge, E., Belinsky, M. G., Chen, Z. S. (2007) ABCC10, ABCC11, and ABCC12. Pflugers Arch. 453, 675-684.
14. Hopper-Borge, E., Xu, X., Shen, T., Shi, Z., Chen, Z. S., Kruh, G. D. (2009) Human multidrug resistance protein 7 (ABCC10) is a resistance factor for nucleoside analogues and epothilone B. Cancer Res. 69, 178-184.
15. Lagas, J. S., van der Kruijssen, C. M., van de Wetering, K., Beijnen, J. H., Schinkel, A. H. (2008) Transport of diclofenac by BCRP (ABCG2) and stimulation of MRP2- (ABCC2-) mediated drug transport by diclofenac and benzbromarone. Drug Metab. Dispos. 37, 129-136.
16. Peng, H., Dong, Z., Qi, J., Yang, Y., Liu, Y., Li, Z., Xu, J., Zhang, J. T. (2009) A novel two mode-acting inhibitor of ABCG2-mediated multidrug transport and resistance in cancer chemotherapy. PLoS. One 4, e5676.
17. Assaraf, Y. G. (2006) The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis. Drug Resist. Updat. 9, 227-246.
18. Randolph, G. J., Angeli, V., Swartz, M. A. (2005) Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat. Rev. Immunol. 5, 617-628. (Pubitemid 41113193)
19. Honig, S. M., Fu, S., Mao, X., Yopp, A., Gunn, M. D., Randolph, G. J., Bromberg, J. S. (2003) FTY720 stimulates multidrug transporter- and cysteinyl leukotriene-dependent T cell chemotaxis to lymph nodes. J. Clin. Invest. 111, 627-637. (Pubitemid 36278581)
20. Raggers, R. J., Vogels, I., van Meer, G. (2001) Multidrug-resistance P-glycoprotein (MDR1) secretes platelet-activating factor. Biochem. J. 357, 859-865. (Pubitemid 32735167)
21. Rao, U. S., Fine, R. L., Scarborough, G. A. (1994) Antiestrogens and steroid hormones: substrates of the human P-glycoprotein. Biochem. Pharmacol. 48, 287-292. (Pubitemid 24243970)
22. Bello-Reuss, E., Ernest, S., Holland, O. B., Hellmich, M. R. (2000) Role of multidrug resistance P-glycoprotein in the secretion of aldosterone by human adrenal NCI-H295 cells. Am. J. Physiol. Cell Physiol. 278, C1256-C1265. (Pubitemid 30432410)
23. Kim, W. Y., Benet, L. Z. (2004) P-glycoprotein (P-gp/MDR1)-mediated efflux of sex-steroid hormones and modulation of P-gp expression in vitro. Pharm. Res. 21, 1284-1293.
24. Yates, C. R., Chang, C., Kearbey, J. D., Yasuda, K., Schuetz, E. G., Miller, D. D., Dalton, J. T., Swaan, P. W. (2003) Structural determinants of P-glycoprotein- mediated transport of glucocorticoids. Pharm. Res. 20, 1794-1803. (Pubitemid 37449453)
25. Huang, L., Hoffman, T., Vore, M. (1998) Adenosine triphosphate-dependent transport of estradiol-17β(β-D-glucuronide) in membrane vesicles by MDR1 expressed in insect cells. Hepatology 28, 1371-1377. (Pubitemid 28493849)
26. Koopmann, J. O., Post, M., Neefjes, J. J., Hammerling, G. J., Momburg, F. (1996) Translocation of long peptides by transporters associated with antigen processing (TAP). Eur. J. Immunol. 26, 1720-1728. (Pubitemid 26283142)
27. Heemels, M. T., Schumacher, T. N., Wonigeit, K., Ploegh, H. L. (1993) Peptide translocation by variants of the transporter associated with antigen processing. Science 262, 2059-2063. (Pubitemid 24041890)
28. Leier, I., Jedlitschky, G., Buchholz, U., Cole, S. P., Deeley, R. G., Keppler, D. (1994) The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J. Biol. Chem. 269, 27807-27810. (Pubitemid 24354499)
29. Leier, I., Jedlitschky, G., Buchholz, U., Center, M., Cole, S. P., Deeley, R. G., Keppler, D. (1996) ATP-dependent glutathione disulphide transport mediated by the MRP gene-encoded conjugate export pump. Biochem. J. 314, 433-437. (Pubitemid 26075650)
30. Mitra, P., Oskeritzian, C. A., Payne, S. G., Beaven, M. A., Milstien, S., Spiegel, S. (2006) Role of ABCC1 in export of sphingosine-1-phosphate from mast cells. Proc. Natl. Acad. Sci. USA 103, 16394-16399. (Pubitemid 44715207)
31. Zelcer, N., Reid, G., Wielinga, P., Kuil, A., van der Heijden, I., Schuetz, J. D., Borst, P. (2003) Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4). Biochem. J. 371, 361-367. (Pubitemid 36547618)
32. Van de Ven, R., de Jong, M. C., Reurs, A. W., Schoonderwoerd, A. J., Jansen, G., Hooijberg, J. H., Scheffer, G. L., de Gruijl, T. D., Scheper, R. J. (2006) Dendritic cells require multidrug resistance protein 1 (ABCC1) transporter activity for differentiation. J. Immunol. 176, 5191-5198.
33. Renes, J., de Vries, E. E., Hooiveld, G. J., Krikken, I., Jansen, P. L., Muller, M. (2000) Multidrug resistance protein MRP1 protects against the toxicity of the major lipid peroxidation product 4-hydroxynonenal. Biochem. J. 350, 555-561. (Pubitemid 30708424)
34. Raggers, R. J., van Helvoort, A., Evers, R., van Meer, G. (1999) The human multidrug resistance protein MRP1 translocates sphingolipid analogs across the plasma membrane. J. Cell Sci. 112 (Pt. 3), 415-422. (Pubitemid 29080663)
35. Dekkers, D. W., Comfurius, P., Schroit, A. J., Bevers, E. M., Zwaal, R. F. (1998) Transbilayer movement of NBD-labeled phospholipids in red blood cell membranes: outward-directed transport by the multidrug resistance protein 1 (MRP1). Biochemistry 37, 14833-14837. (Pubitemid 28487590)
36. Zaman, G. J., Lankelma, J., van Tellingen, O., Beijnen, J., Dekker, H., Paulusma, C., Oude Elferink, R. P., Baas, F., Borst, P. (1995) Role of glutathione in the export of compounds from cells by the multidrug-resistance- associated protein. Proc. Natl. Acad. Sci. USA 92, 7690-7694.
37. Jedlitschky, G., Leier, I., Buchholz, U., Hummel-Eisenbeiss, J., Burchell, B., Keppler, D. (1997) ATP-dependent transport of bilirubin glucuronides by the multidrug resistance protein MRP1 and its hepatocyte canalicular isoform MRP2. Biochem. J. 327, 305-310. (Pubitemid 27455494)
38. Rigato, I., Pascolo, L., Fernetti, C., Ostrow, J. D., Tiribelli, C. (2004) The human multidrug-resistance-associated protein MRP1 mediates ATP-dependent transport of unconjugated bilirubin. Biochem. J. 383, 335-341. (Pubitemid 39446695)
39. Jedlitschky, G., Leier, I., Buchholz, U., Barnouin, K., Kurz, G., Keppler, D. (1996) Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res. 56, 988-994. (Pubitemid 26065391)
40. Cui, Y., Konig, J., Buchholz, J. K., Spring, H., Leier, I., Keppler, D. (1999) Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. Mol. Pharmacol. 55, 929-937. (Pubitemid 29214613)
41. Evers, R., Kool, M., van Deemter, L., Janssen, H., Calafat, J., Oomen, L. C., Paulusma, C. C., Oude Elferink, R. P., Baas, F., Schinkel, A. H., Borst, P. (1998) Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA. J. Clin. Invest. 101, 1310-1319. (Pubitemid 28166828)
42. Evers, R., de Haas, M., Sparidans, R., Beijnen, J., Wielinga, P. R., Lankelma, J., Borst, P. (2000) Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione export. Br. J. Cancer 83, 375-383. (Pubitemid 30453579)
43. Zeng, H., Liu, G., Rea, P. A., Kruh, G. D. (2000) Transport of amphipathic anions by human multidrug resistance protein 3. Cancer Res. 60, 4779-4784. (Pubitemid 30701488)
44. Lee, Y. M., Cui, Y., Konig, J., Risch, A., Jager, B., Drings, P., Bartsch, H., Keppler, D., Nies, A. T. (2004) Identification and functional characterization of the natural variant MRP3-Arg1297His of human multidrug resistance protein 3 (MRP3/ABCC3). Pharmacogenetics 14, 213-223. (Pubitemid 38530513)
45. Rius, M., Hummel-Eisenbeiss, J., Keppler, D. (2008) ATP-dependent transport of leukotrienes B4 and C4 by the multidrug resistance protein ABCC4 (MRP4). J. Pharmacol. Exp. Ther. 324, 86-94. (Pubitemid 350294174)
46. Reid, G., Wielinga, P., Zelcer, N., van der Heijden, I., Kuil, A., de Haas, M., Wijnholds, J., Borst, P. (2003) The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs. Proc. Natl. Acad. Sci. USA 100, 9244-9249. (Pubitemid 37033914)
47. Chen, Z. S., Lee, K., Kruh, G. D. (2001) Transport of cyclic nucleotides and estradiol 17-β-D-glucuronide by multidrug resistance protein 4. Resistance to 6-mercaptopurine and 6-thioguanine. J. Biol. Chem. 276, 33747-33754. (Pubitemid 37384594)
48. Wielinga, P. R., van der Heijden, I., Reid, G., Beijnen, J. H., Wijnholds, J., Borst, P. (2003) Characterization of the MRP4- and MRP5-mediated transport of cyclic nucleotides from intact cells. J. Biol. Chem. 278, 17664-17671. (Pubitemid 36799368)
49. Smeets, P. H., Van Aubel, R. A., Wouterse, A. C., van den Heuvel, J. J., Russel, F. G. (2004) Contribution of multidrug resistance protein 2 (MRP2/ABCC2) to the renal excretion of p-aminohippurate (PAH) and identification of MRP4 (ABCC4) as a novel PAH transporter. J. Am. Soc. Nephrol. 15, 2828-2835.
50. Van Aubel, R. A., Smeets, P. H., van den Heuvel, J. J., Russel, F. G. (2005) Human organic anion transporter MRP4 (ABCC4) is an efflux pump for the purine end metabolite urate with multiple allosteric substrate binding sites. Am. J. Physiol. Renal Physiol. 288, F327-F333.
51. Rius, M., Hummel-Eisenbeiss, J., Hofmann, A. F., Keppler, D. (2006) Substrate specificity of human ABCC4 (MRP4)-mediated cotransport of bile acids and reduced glutathione. Am. J. Physiol. Gastrointest. Liver Physiol. 290, G640-G649.
52. Wielinga, P., Hooijberg, J. H., Gunnarsdottir, S., Kathmann, I., Reid, G., Zelcer, N., van der Born, K., de Haas, M., van der Heijden, I., Kaspers, G., Wijnholds, J., Jansen, G., Peters, G., Borst, P. (2005) The human multidrug resistance protein MRP5 transports folates and can mediate cellular resistance against antifolates. Cancer Res. 65, 4425-4430. (Pubitemid 40775682)
53. Wijnholds, J., Mol, C. A., van Deemter, L., de Haas, M., Scheffer, G. L., Baas, F., Beijnen, J. H., Scheper, R. J., Hatse, S., De Clercq, E., Balzarini, J., Borst, P. (2000) Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs. Proc. Natl. Acad. Sci. USA 97, 7476-7481. (Pubitemid 30431488)
54. Belinsky, M. G., Chen, Z. S., Shchaveleva, I., Zeng, H., Kruh, G. D. (2002) Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6). Cancer Res. 62, 6172-6177. (Pubitemid 35244468)
55. Chen, Z. S., Hopper-Borge, E., Belinsky, M. G., Shchaveleva, I., Kotova, E., Kruh, G. D. (2003) Characterization of the transport properties of human multidrug resistance protein 7 (MRP7, ABCC10). Mol. Pharmacol. 63, 351-358. (Pubitemid 36158370)
56. Chen, Z. S., Guo, Y., Belinsky, M. G., Kotova, E., Kruh, G. D. (2005) Transport of bile acids, sulfated steroids, estradiol 17-β-D-glucuronide, and leukotriene C4 by human multidrug resistance protein 8 (ABCC11). Mol. Pharmacol. 67, 545-557. (Pubitemid 40216748)
57. Guo, Y., Kotova, E., Chen, Z. S., Lee, K., Hopper-Borge, E., Belinsky, M. G., Kruh, G. D. (2003) MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2′,3′-dideoxycytidine and 9′-(2′-phosphonylmethoxyethyl) adenine. J. Biol. Chem. 278, 29509-29514. (Pubitemid 36962331)
58. Suzuki, M., Suzuki, H., Sugimoto, Y., Sugiyama, Y. (2003) ABCG2 transports sulfated conjugates of steroids and xenobiotics. J. Biol. Chem. 278, 22644-22649. (Pubitemid 36830322)
59. Jonker, J. W., Buitelaar, M., Wagenaar, E., Van Der Valk, M. A., Scheffer, G. L., Scheper, R. J., Plosch, T., Kuipers, F., Elferink, R. P., Rosing, H., Beijnen, J. H., Schinkel, A. H. (2002) The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria. Proc. Natl. Acad. Sci. USA 99, 15649-15654. (Pubitemid 35403986)
60. Robey, R. W., Medina-Perez, W. Y., Nishiyama, K., Lahusen, T., Miyake, K., Litman, T., Senderowicz, A. M., Ross, D. D., Bates, S. E. (2001) Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells. Clin. Cancer Res. 7, 145-152. (Pubitemid 32110217)
61. Chen, Z. S., Robey, R. W., Belinsky, M. G., Shchaveleva, I., Ren, X. Q., Sugimoto, Y., Ross, D. D., Bates, S. E., Kruh, G. D. (2003) Transport of methotrexate, methotrexate polyglutamates, and 17β-estradiol 17-(β-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport. Cancer Res. 63, 4048-4054. (Pubitemid 36917926)
62. Van Herwaarden, A. E., Jonker, J. W., Wagenaar, E., Brinkhuis, R. F., Schellens, J. H., Beijnen, J. H., Schinkel, A. H. (2003) The breast cancer resistance protein (Bcrp1/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Cancer Res. 63, 6447-6452. (Pubitemid 37255195)
63. Woehlecke, H., Pohl, A., der-Baerens, N., Lage, H., Herrmann, A. (2003) Enhanced exposure of phosphatidylserine in human gastric carcinoma cells overexpressing the half-size ABC transporter BCRP (ABCG2). Biochem. J. 376, 489-495.
64. Janeway Jr., C. A., Medzhitov, R. (2002) Innate immune recognition. Annu. Rev. Immunol. 20, 197-216.
65. Janeway Jr., C. A. (2001) How the immune system protects the host from infection. Microbes Infect. 3, 1167-1171.
66. Chaudhary, P. M., Roninson, I. B. (1991) Expression and activity of Pglycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 66, 85-94.
67. Laupeze, B., Amiot, L., Payen, L., Drenou, B., Grosset, J. M., Lehne, G., Fauchet, R., Fardel, O. (2001) Multidrug resistance protein (MRP) activity in normal mature leukocytes and CD34-positive hematopoietic cells from peripheral blood. Life Sci. 68, 1323-1331. (Pubitemid 32168035)
68. Steinbach, D., Wittig, S., Cario, G., Viehmann, S., Mueller, A., Gruhn, B., Haefer, R., Zintl, F., Sauerbrey, A. (2003) The multidrug resistance-associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male patients and T-cell immunophenotype. Blood 102, 4493-4498. (Pubitemid 37494115)
69. Zhou, S., Schuetz, J. D., Bunting, K. D., Colapietro, A. M., Sampath, J., Morris, J. J., Lagutina, I., Grosveld, G. C., Osawa, M., Nakauchi, H., Sorrentino, B. P. (2001) The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat. Med. 7, 1028-1034. (Pubitemid 32937383)
70. Van de Ven, R., Scheffer, G. L., Reurs, A. W., Lindenberg, J. J., Oerlemans, R., Jansen, G., Gillet, J. P., Glasgow, J. N., Pereboev, A., Curiel, D. T., Scheper, R. J., de Gruijl, T. D. (2008) A role for multidrug resistance protein 4 (MRP4; ABCC4) in human dendritic cell migration. Blood 112, 2353-2359.
71. Ludescher, C., Pall, G., Irschick, E. U., Gastl, G. (1998) Differential activity of P-glycoprotein in normal blood lymphocyte subsets. Br. J. Haematol. 101, 722-727. (Pubitemid 28308522)
72. Langmann, T., Mauerer, R., Schmitz, G. (2006) Human ATP-binding cassette transporter TaqMan low-density array: analysis of macrophage differentiation and foam cell formation. Clin. Chem. 52, 310-313. (Pubitemid 43185496)
73. Skazik, C., Heise, R., Bostanci, O., Paul, N., Denecke, B., Joussen, S., Kiehl, K., Merk, H. F., Zwadlo-Klarwasser, G., Baron, J. M. (2008) Differential expression of influx and efflux transport proteins in human antigen presenting cells. Exp. Dermatol. 17, 739-747.
74. Drach, D., Zhao, S., Drach, J., Mahadevia, R., Gattringer, C., Huber, H., Andreeff, M. (1992) Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype. Blood 80, 2729-2734.
75. Wirths, S., Lanzavecchia, A. (2005) ABCB1 transporter discriminates human resting naive B cells from cycling transitional and memory B cells. Eur. J. Immunol. 35, 3433-3441. (Pubitemid 43025524)
76. Vasquez, E. M., Petrenko, Y., Jacobssen, V., Sifontis, N. M., Testa, G., Sankary, H., Benedetti, E. (2005) An assessment of P-glycoprotein expression and activity in peripheral blood lymphocytes of transplant candidates. Transplant. Proc. 37, 175-177. (Pubitemid 40459727)
77. Albermann, N., Schmitz-Winnenthal, F. H., Z'graggen, K., Volk, C., Hoffmann, M. M., Haefeli, W. E., Weiss, J. (2005) Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver. Biochem. Pharmacol. 70, 949-958.
78. Elliott, J. I., Raguz, S., Higgins, C. F. (2004) Multidrug transporter activity in lymphocytes. Br. J. Pharmacol. 143, 899-907.
79. Oselin, K., Mrozikiewicz, P. M., Pahkla, R., Roots, I. (2003) Quantitative determination of the human MRP1 and MRP2 mRNA expression in FACS-sorted peripheral blood CD4+, CD8+, CD19+, and CD56+ cells. Eur. J. Haematol. 71, 119-123.
80. Klimecki, W. T., Futscher, B. W., Grogan, T. M., Dalton, W. S. (1994) P-glycoprotein expression and function in circulating blood cells from normal volunteers. Blood 83, 2451-2458. (Pubitemid 24135836)
81. Robbiani, D. F., Finch, R. A., Jager, D., Muller, W. A., Sartorelli, A. C., Randolph, G. J. (2000) The leukotriene C(4) transporter MRP1 regulates CCL19 (MIP-3β, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell 103, 757-768.
82. Chen, W., Hara, K., Tian, Q., Zhao, K., Yoshitomi, T. (2007) Existence of small slow-cycling Langerhans cells in the limbal basal epithelium that express ABCG2. Exp. Eye Res. 84, 626-634. (Pubitemid 46400630)
83. Randolph, G. J., Beaulieu, S., Pope, M., Sugawara, I., Hoffman, L., Steinman, R. M., Muller, W. A. (1998) A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels. Proc. Natl. Acad. Sci. USA 95, 6924-6929. (Pubitemid 28278083)
84. Schroeijers, A. B., Reurs, A. W., Scheffer, G. L., Stam, A. G., de Jong, M. C., Rustemeyer, T., Wiemer, E. A., de Gruijl, T. D., Scheper, R. J. (2002) Up-regulation of drug resistance-related vaults during dendritic cell development. J. Immunol. 168, 1572-1578. (Pubitemid 34135751)
85. Laupeze, B., Amiot, L., Bertho, N., Grosset, J. M., Lehne, G., Fauchet, R., Fardel, O. (2001) Differential expression of the efflux pumps P-glycoprotein and multidrug resistance-associated protein in human monocyte-derived dendritic cells. Hum. Immunol. 62, 1073-1080. (Pubitemid 32971384)
86. Szatmari, I., Vamosi, G., Brazda, P., Balint, B. L., Benko, S., Szeles, L., Jeney, V., Ozvegy-Laczka, C., Szanto, A., Barta, E., Balla, J., Sarkadi, B., Nagy, L. (2006) Peroxisome proliferator-activated receptor γ-regulated ABCG2 expression confers cytoprotection to human dendritic cells. J. Biol. Chem. 281, 23812-23823. (Pubitemid 44274157)
87. Jorajuria, S., Dereuddre-Bosquet, N., Naissant-Storck, K., Dormont, D., Clayette, P. (2004) Differential expression levels of MRP1, MRP4, and MRP5 in response to human immunodeficiency virus infection in human macrophages. Antimicrob. Agents Chemother. 48, 1889-1891. (Pubitemid 38544407)
88. Van der Heijden, J. W., Oerlemans, R., Tak, P. P., Assaraf, Y. G., Kraan, M. C., Scheffer, G., van der Laken, C. J., Lems, W. F., Scheper, R. J., Dijkmans, B. A., Jansen, G. (2009) Involvement of breast cancer resistance protein expression on RA synovial tissue macrophages in resistance to methotrexate and leflunomide. Arthritis Rheum. 60, 669-677.
89. Sjolinder, M., Tornhamre, S., Claesson, H. E., Hydman, J., Lindgren, J. (1999) Characterization of a leukotriene C4 export mechanism in human platelets: possible involvement of multidrug resistance-associated protein 1. J. Lipid Res. 40, 439-446. (Pubitemid 29116147)
90. Jedlitschky, G., Tirschmann, K., Lubenow, L. E., Nieuwenhuis, H. K., Akkerman, J. W., Greinacher, A., Kroemer, H. K. (2004) The nucleotide transporter MRP4 (ABCC4) is highly expressed in human platelets and present in dense granules, indicating a role in mediator storage. Blood 104, 3603-3610. (Pubitemid 39564434)
91. Abraham, E. H., Shrivastav, B., Salikhova, A. Y., Sterling, K. M., Johnston, N., Guidotti, G., Scala, S., Litman, T., Chan, K. C., Arceci, R. J., Steiglitz, K., Herscher, L., Okunieff, P. (2001) Cellular and biophysical evidence for interactions between adenosine triphosphate and P-glycoprotein substrates: functional implications for adenosine triphosphate/drug cotransport in P-glycoprotein overexpressing tumor cells and in P-glycoprotein low-level expressing erythrocytes. Blood Cells Mol. Dis. 27, 181-200.
92. Wu, C. P., Klokouzas, A., Hladky, S. B., Ambudkar, S. V., Barrand, M. A. (2005) Interactions of mefloquine with ABC proteins, MRP1 (ABCC1) and MRP4 (ABCC4) that are present in human red cell membranes. Biochem. Pharmacol. 70, 500-510. (Pubitemid 40978539)
93. Zhou, S., Zong, Y., Ney, P. A., Nair, G., Stewart, C. F., Sorrentino, B. P. (2005) Increased expression of the Abcg2 transporter during erythroid maturation plays a role in decreasing cellular protoporphyrin IX levels. Blood 105, 2571-2576. (Pubitemid 40387061)
94. Raaijmakers, M. H., de Grouw, E. P., Heuver, L. H., van der Reijden, B. A., Jansen, J. H., Scheffer, G., Scheper, R. J., de Witte, T. J., Raymakers, R. A. (2005) Impaired breast cancer resistance protein mediated drug transport in plasma cells in multiple myeloma. Leuk. Res. 29, 1455-1458. (Pubitemid 41562248)
95. Gupta, S., Kim, C. H., Tsuruo, T., Gollapudi, S. (1992) Preferential expression and activity of multidrug resistance gene 1 product (P-glycoprotein), a functionally active efflux pump, in human CD8+ T cells: a role in cytotoxic effector function. J. Clin. Immunol. 12, 451-458.
96. Funk, C. D. (2001) Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294, 1871-1875.
97. Cole, S. P., Deeley, R. G. (2006) Transport of glutathione and glutathione conjugates by MRP1. Trends Pharmacol. Sci. 27, 438-446.
98. Samuelsson, B., Dahlen, S. E., Lindgren, J. A., Rouzer, C. A., Serhan, C. N. (1987) Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 237, 1171-1176. (Pubitemid 17131222)
99. Leitner, H. M., Kachadourian, R., Day, B. J. (2007) Harnessing drug resistance: using ABC transporter proteins to target cancer cells. Biochem. Pharmacol. 74, 1677-1685. (Pubitemid 350088674)
100. Jedlitschky, G., Burchell, B., Keppler, D. (2000) The multidrug resistance protein 5 functions as an ATP-dependent export pump for cyclic nucleotides. J. Biol. Chem. 275, 30069-30074. (Pubitemid 30751313)
101. Imai, Y., Asada, S., Tsukahara, S., Ishikawa, E., Tsuruo, T., Sugimoto, Y. (2003) Breast cancer resistance protein exports sulfated estrogens but not free estrogens. Mol. Pharmacol. 64, 610-618. (Pubitemid 37048564)
102. Mambula, S. S., Calderwood, S. K. (2006) Heat shock protein 70 is secreted from tumor cells by a nonclassical pathway involving lysosomal endosomes. J. Immunol. 177, 7849-7857.
103. Wein, S., Fauroux, M., Laffitte, J., de Nadaï, P., Guaini, C., Pons, F., Comera, C. (2004) Mediation of annexin 1 secretion by a probenecidsensitive ABC-transporter in rat inflamed mucosa. Biochem. Pharmacol. 67, 1195-1202. (Pubitemid 38296797)
104. Drach, J., Gsur, A., Hamilton, G., Zhao, S., Angerler, J., Fiegl, M., Zojer, N., Raderer, M., Haberl, I., Andreeff, M., Huber, H. (1996) Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-γ in normal human T lymphocytes. Blood 88, 1747-1754. (Pubitemid 26307071)
105. Raghu, G., Park, S. W., Roninson, I. B., Mechetner, E. B. (1996) Monoclonal antibodies against P-glycoprotein, an MDR1 gene product, inhibit interleukin-2 release from PHA-activated lymphocytes. Exp. Hematol. 24, 1258-1264. (Pubitemid 26276589)
106. Frank, M. H., Denton, M. D., Alexander, S. I., Khoury, S. J., Sayegh, M. H., Briscoe, D. M. (2001) Specific MDR1 P-glycoprotein blockade inhibits human alloimmune T cell activation in vitro. J. Immunol. 166, 2451-2459.
107. Pawlik, A., Baskiewicz-Masiuk, M., Machalinski, B., Kurzawski, M., Gawronska-Szklarz, B. (2005) Involvement of C3435T and G2677T multidrug resistance gene polymorphisms in release of cytokines from peripheral blood mononuclear cells treated with methotrexate and dexamethasone. Eur. J. Pharmacol. 528, 27-36. (Pubitemid 41773648)
108. Pendse, S. S., Behjati, S., Schatton, T., Izawa, A., Sayegh, M. H., Frank, M. H. (2006) P-glycoprotein functions as a differentiation switch in antigen presenting cell maturation. Am. J. Transplant. 6, 2884-2893. (Pubitemid 44777918)
109. Eisenbraun, M. D., Miller, R. A. (1999) Mdr1a-encoded P-glycoprotein is not required for peripheral T cell proliferation, cytokine release, or cytotoxic effector function in mice. J. Immunol. 163, 2621-2627.
110. Neefjes, J. J., Momburg, F., Hammerling, G. J. (1993) Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. Science 261, 769-771. (Pubitemid 23278394)
111. Zhang, J., Alston, M. A., Huang, H., Rabin, R. L. (2006) Human T cell cytokine responses are dependent on multidrug resistance protein-1. Int. Immunol. 18, 485-493. (Pubitemid 43329611)
112. Ho, E. A., Piquette-Miller, M. (2006) Regulation of multidrug resistance by pro-inflammatory cytokines. Curr. Cancer Drug Targets 6, 295-311. (Pubitemid 43961865)
113. Liptrott, N. J., Penny, M., Bray, P. G., Sathish, J., Khoo, S. H., Back, D. J., Owen, A. (2009) The impact of cytokines on the expression of drug transporters, cytochrome P450 enzymes and chemokine receptors in human PBMC. Br. J. Pharmacol. 156, 497-508.
114. Blom, B., Spits, H. (2006) Development of human lymphoid cells. Annu. Rev. Immunol. 24, 287-320.
115. Raaijmakers, M. H. (2007) ATP-binding-cassette transporters in hematopoietic stem cells and their utility as therapeutical targets in acute and chronic myeloid leukemia. Leukemia 21, 2094-2102.
116. Oevermann, L., Scheitz, J., Starke, K., Kock, K., Kiefer, T., Dolken, G., Niessen, J., Greinacher, A., Siegmund, W., Zygmunt, M., Kroemer, H. K., Jedlitschky, G., Ritter, C. A. (2009) Hematopoietic stem cell differentiation affects expression and function of MRP4 (ABCC4), a transport protein for signaling molecules and drugs. Int. J. Cancer 124, 2303-2311.
117. Mogi, M., Yang, J., Lambert, J. F., Colvin, G. A., Shiojima, I., Skurk, C., Summer, R., Fine, A., Quesenberry, P. J., Walsh, K. (2003) Akt signaling regulates side population cell phenotype via Bcrp1 translocation. J. Biol. Chem. 278, 39068-39075. (Pubitemid 37221810)
118. Scharenberg, C. W., Harkey, M. A., Torok-Storb, B. (2002) The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 99, 507-512.
119. Krishnamurthy, P., Ross, D. D., Nakanishi, T., Bailey-Dell, K., Zhou, S., Mercer, K. E., Sarkadi, B., Sorrentino, B. P., Schuetz, J. D. (2004) The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme. J. Biol. Chem. 279, 24218-24225. (Pubitemid 38725283)
120. Zhou, S., Morris, J. J., Barnes, Y., Lan, L., Schuetz, J. D., Sorrentino, B. P. (2002) Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo. Proc. Natl. Acad. Sci. USA 99, 12339-12344.
121. Aderem, A., Underhill, D. M. (1999) Mechanisms of phagocytosis in macrophages. Annu. Rev. Immunol. 17, 593-623.
122. Oram, J. F., Vaughan, A. M. (2006) ATP-binding cassette cholesterol transporters and cardiovascular disease. Circ. Res. 99, 1031-1043. (Pubitemid 44729927)
123. Leite, D. F., Echevarria-Lima, J., Ferreira, S. C., Calixto, J. B., Rumjanek, V. M. (2007) ABCC transporter inhibition reduces zymosan-induced peritonitis. J. Leukoc. Biol. 82, 630-637. (Pubitemid 47367155)
124. Schultz, M. J., Wijnholds, J., Peppelenbosch, M. P., Vervoordeldonk, M. J., Speelman, P., van Deventer, S. J., Borst, P., van der Poll, T. (2001) Mice lacking the multidrug resistance protein 1 are resistant to Streptococcus pneumoniae-induced pneumonia. J. Immunol. 166, 4059-4064. (Pubitemid 32224936)
125. Wijnholds, J., Evers, R., van Leusden, M. R., Mol, C. A., Zaman, G. J., Mayer, U., Beijnen, J. H., van der Valk, M., Krimpenfort, P., Borst, P. (1997) Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Nat. Med. 3, 1275-1279. (Pubitemid 27508831)
126. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. J., Pulendran, B., Palucka, K. (2000) Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767-811.
127. Van de Ven, R., Scheffer, G. L., Scheper, R. J., de Gruijl, T. D. (2009) The ABC of dendritic cell development and function. Trends Immunol., 30, 421-429.
128. Reid, G., Wielinga, P., Zelcer, N., De Haas, M., van Deemter, L., Wijnholds, J., Balzarini, J., Borst, P. (2003) Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5. Mol. Pharmacol. 63, 1094-1103. (Pubitemid 36529928)
129. Van de Ven, R., de Groot, J., Reurs, A. W., Wijnands, P. G., van de Wetering, K., Schuetz, J. D., de Gruijl, T. D., Scheper, R. J., Scheffer, G. L. (2009) Unimpaired immune functions in the absence of Mrp4 (Abcc4). Immunol. Lett. 124, 81-87.
130. Hu, Z. B., Ma, W., Zaborski, M., MacLeod, R., Quentmeier, H., Drexler, H. G. (1996) Establishment and characterization of two novel cytokineresponsive
131. Masterson, A. J., Sombroek, C. C., de Gruijl, T. D., Graus, Y. M., van der Vliet, H. J., Lougheed, S. M., van den Eertwegh, A. J., Pinedo, H. M., Scheper, R. J. (2002) MUTZ-3, a human cell line model for the cytokine-induced differentiation of dendritic cells from CD34+ precursors. Blood 100, 701-703.
132. Licht, T., Pastan, I., Gottesman, M., Herrmann, F. (1994) P-glycoprotein-mediated multidrug resistance in normal and neoplastic hematopoietic cells. Ann. Hematol. 69, 159-171. (Pubitemid 24314384)
133. Maillefert, J. F., Maynadie, M., Tebib, J. G., Aho, S., Walker, P., Chatard, C., Dulieu, V., Bouvier, M., Carli, P. M., Tavernier, C. (1996) Expression of the multidrug resistance glycoprotein 170 in the peripheral blood lymphocytes of rheumatoid arthritis patients. The percentage of lymphocytes expressing glycoprotein 170 is increased in patients treated with prednisolone. Br. J. Rheumatol. 35, 430-435. (Pubitemid 26155700)
134. Llorente, L., Richaud-Patin, Y., Díaz-Borjón, A., Alvarado de la Barrera, C., Jakez-Ocampo, J., de la Fuente, H., Gonzalez-Amaro, R., Diaz-Jouanen, E. (2000) Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders. Part I: increased P-glycoprotein activity in lymphocytes from rheumatoid arthritis patients might influence disease outcome. Joint Bone Spine 67, 30-39.
135. Tsujimura, S., Saito, K., Nakayamada, S., Tanaka, Y. (2007) Relevance of multidrug resistance 1 and P-glycoprotein to drug resistance in patients with systemic lupus erythematosus. Histol. Histopathol. 22, 465-468. (Pubitemid 46647260)
136. Limpens, J., Scheper, R. J. (1991) Inhibition of T suppressor cell function by local administration of an active cyclophosphamide derivative at the sensitization site. Clin. Exp. Immunol. 84, 383-388.
137. Donnenberg, V. S., Burckart, G. J., Zeevi, A., Griffith, B. P., Iacono, A., McCurry, K. R., Wilson, J. W., Donnenberg, A. D. (2004) P-glycoprotein activity is decreased in CD4+ but not CD8+ lung allograft-infiltrating T cells during acute cellular rejection. Transplantation 77, 1699-1706. (Pubitemid 38780536)
138. Guimond, M., Balassy, A., Barrette, M., Brochu, S., Perreault, C., Roy, D. C. (2002) P-glycoprotein targeting: a unique strategy to selectively eliminate immunoreactive T cells. Blood 100, 375-382. (Pubitemid 34761096)
139. Pilarski, L. M., Paine, D., McElhaney, J. E., Cass, C. E., Belch, A. R. (1995) Multidrug transporter P-glycoprotein 170 as a differentiation antigen on normal human lymphocytes and thymocytes: modulation with differentiation stage and during aging. Am. J. Hematol. 49, 323-335.
140. Toornvliet, R., van Berckel, B. N., Luurtsema, G., Lubberink, M., Geldof, A. A., Bosch, T. M., Oerlemans, R., Lammertsma, A. A., Franssen, E. J. (2006) Effect of age on functional P-glycoprotein in the blood-brain barrier measured by use of (R)-[(11)C]verapamil and positron emission tomography. Clin. Pharmacol. Ther. 79, 540-548. (Pubitemid 43841828)
141. Machado, C. G., Calado, R. T., Garcia, A. B., Falcao, R. P. (2003) Age-related changes of the multidrug resistance P-glycoprotein function in normal human peripheral blood T lymphocytes. Braz. J. Med. Biol. Res. 36, 1653-1657.
142. Calado, R. T., Machado, C. G., Carneiro, J. J., Garcia, A. B., Falcao, R. P. (2003) Age-related changes of P-glycoprotein-mediated rhodamine 123 efflux in normal human bone marrow hematopoietic stem cells. Leukemia 17, 816-818.
143. Aggarwal, S., Tsuruo, T., Gupta, S. (1997) Altered expression and function of P-glycoprotein (170 kDa), encoded by the MDR 1 gene, in T cell subsets from aging humans. J. Clin. Immunol. 17, 448-454. (Pubitemid 28008102)
144. Brenner, S. S., Klotz, U. (2004) P-glycoprotein function in the elderly. Eur. J. Clin. Pharmacol. 60, 97-102.
145. Prechtl, S., Roellinghoff, M., Scheper, R., Cole, S. P., Deeley, R. G., Lohoff, M. (2000) The multidrug resistance protein 1: a functionally important activation marker for murine Th1 cells. J. Immunol. 164, 754-761. (Pubitemid 30043698)
146. Kleemann, P., Casper, B., Huber, M., Schuetz, J. D., Lohoff, M. (2006) Multidrug-resistance-associated protein 1 (Mrp1) is probably not required for murine Th cell activation. Int. Immunol. 18, 1603-1606. (Pubitemid 44605581)
147. Dalton, W. S. (1997) Detection of multidrug resistance gene expression in multiple myeloma. Leukemia 11, 1166-1169. (Pubitemid 27345972)
148. Pilarski, L. M., Szczepek, A. J., Belch, A. R. (1997) Deficient drug transporter function of bone marrow-localized and leukemic plasma cells in multiple myeloma. Blood 90, 3751-3759.
149. Turner, J. G., Gump, J. L., Zhang, C., Cook, J. M., Marchion, D., Hazlehurst, L., Munster, P., Schell, M. J., Dalton, W. S., Sullivan, D. M. (2006) ABCG2 expression, function, and promoter methylation in human multiple myeloma. Blood 108, 3881-3889. (Pubitemid 44864572)
150. Fox, E. J., Lewis, D. E., Deemer, K. P., ElMasry, M. N., Rich, R. R. (1987) T suppressor cell growth factor and anti-CD3 antibodies stimulate reciprocal subsets of T lymphocytes. J. Exp. Med. 166, 404-418.
151. N'cho, M., Hobbs, J. A., Brahmi, Z. (1999) Over-expression of multidrug resistance P-glycoprotein inhibits NK granule-mediated lytic ability without affecting the Fas lytic pathway. Hum. Immunol. 60, 223-230.
152. Takahashi, M., Misawa, Y., Watanabe, N., Kawanishi, T., Tanaka, H., Shigenobu, K., Kobayashi, Y. (1999) Role of P-glycoprotein in human natural killer-like cell line-mediated cytotoxicity. Exp. Cell Res. 253, 396-402. (Pubitemid 30003100)
153. Escors, D., Lopes, L., Lin, R., Hiscott, J., Akira, S., Davis, R. J., Collins, M. K. (2008) Targeting dendritic cell signaling to regulate the response to immunization. Blood 111, 3050-3061.
154. Nakahara, T., Moroi, Y., Uchi, H., Furue, M. (2006) Differential role of MAPK signaling in human dendritic cell maturation and Th1/Th2 engagement. J. Dermatol. Sci. 42, 1-11. (Pubitemid 43384125)
155. Jung, I. D., Lee, J. S., Kim, Y. J., Jeong, Y. I., Lee, C. M., Lee, M. G., Ahn, S. C., Park, Y. M. (2007) Sphingosine kinase inhibitor suppresses dendritic cell migration by regulating chemokine receptor expression and impairing p38 mitogen-activated protein kinase. Immunology 121, 533-544.
156. Barancik, M., Bohacova, V., Kvackajova, J., Hudecova, S., Krizanova, O., Breier, A. (2001) SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistance. Eur. J. Pharm. Sci. 14, 29-36. (Pubitemid 32655412)
157. Guo, X., Ma, N., Wang, J., Song, J., Bu, X., Cheng, Y., Sun, K., Xiong, H., Jiang, G., Zhang, B., Wu, M., Wei, L. (2008) Increased p38-MAPK is responsible for chemotherapy resistance in human gastric cancer cells. BMC Cancer 8, 375.
158. Shinoda, C., Maruyama, M., Fujishita, T., Dohkan, J., Oda, H., Shinoda, K., Yamada, T., Miyabayashi, K., Hayashi, R., Kawagishi, Y., Fujita, T., Matsui, S., Sugiyama, E., Muraguchi, A., Kobayashi, M. (2005) Doxorubicin induces expression of multidrug resistance-associated protein 1 in human small cell lung cancer cell lines by the c-jun N-terminal kinase pathway. Int. J. Cancer 117, 21-31.
159. Bailey-Dell, K. J., Hassel, B., Doyle, L. A., Ross, D. D. (2001) Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene. Biochim. Biophys. Acta 1520, 234-241. (Pubitemid 32868794)
160. Yu, Q., Kovacs, C., Yue, F. Y., Ostrowski, M. A. (2004) The role of the p38 mitogen-activated protein kinase, extracellular signal-regulated kinase, and phosphoinositide-3-OH kinase signal transduction pathways in CD40 ligand-induced dendritic cell activation and expansion of virus-specific CD8+ T cell memory responses. J. Immunol. 172, 6047-6056. (Pubitemid 38621206)
161. Chiarini, F., Del, S. M., Mongiorgi, S., Gaboardi, G. C., Cappellini, A., Mantovani, I., Follo, M. Y., McCubrey, J. A., Martelli, A. M. (2008) The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute leukemia cells by a JNK-dependent mechanism. Leukemia 22, 1106-1116. (Pubitemid 351833776)
162. Tazzari, P. L., Cappellini, A., Ricci, F., Evangelisti, C., Papa, V., Grafone, T., Martinelli, G., Conte, R., Cocco, L., McCubrey, J. A., Martelli, A. M. (2007) Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blasts. Leukemia 21, 427-438. (Pubitemid 46306553)
163. Bleau, A. M., Hambardzumyan, D., Ozawa, T., Fomchenko, E. I., Huse, J. T., Brennan, C. W., Holland, E. C. (2009) PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Cell Stem Cell 4, 226-235.
164. Garvey, B. (2008) Rituximab in the treatment of autoimmune haematological disorders. Br. J. Haematol. 141, 149-169.
165. Meriggioli, M. N., Sanders, D. B. (2009) Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol. 8, 475-490.
166. Smolen, J. S., Aletaha, D., Koeller, M., Weisman, M. H., Emery, P. (2007) New therapies for treatment of rheumatoid arthritis. Lancet 370, 1861-1874. (Pubitemid 350180008)
167. Oerlemans, R., van der Heijden, J., Vink, J., Dijkmans, B. A., Kaspers, G. J., Lems, W. F., Scheffer, G. L., Ifergan, I., Scheper, R. J., Cloos, J., Assaraf, Y. G., Jansen, G. (2006) Acquired resistance to chloroquine in human CEM T cells is mediated by multidrug resistance-associated protein 1 and provokes high levels of cross-resistance to glucocorticoids. Arthritis Rheum. 54, 557-568.
168. Van der Heijden, J. W., Dijkmans, B. A., Scheper, R. J., Jansen, G. (2007) Drug insight: resistance to methotrexate and other disease-modifying antirheumatic drugs-from bench to bedside. Nat. Clin. Pract. Rheumatol. 3, 26-34.
169. Van der Heijden, J., de Jong, M. C., Dijkmans, B. A., Lems, W. F., Oerlemans, R., Kathmann, I., Schalkwijk, C. G., Scheffer, G. L., Scheper, R. J., Jansen, G. (2004) Development of sulfasalazine resistance in human T cells induces expression of the multidrug resistance transporter ABCG2 (BCRP) and augmented production of TNFα. Ann. Rheum. Dis. 63, 138-143. (Pubitemid 38122131)
170. Zaher, H., Khan, A. A., Palandra, J., Brayman, T. G., Yu, L., Ware, J. A. (2006) Breast cancer resistance protein (Bcrp/abcg2) is a major determinant of sulfasalazine absorption and elimination in the mouse. Mol. Pharm. 3, 55-61. (Pubitemid 43331751)
171. Tsujimura, S., Saito, K., Nawata, M., Nakayamada, S., Tanaka, Y. (2008) Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis. Ann. Rheum. Dis. 67, 380-388. (Pubitemid 351281275)
172. Yudoh, K., Matsuno, H., Nakazawa, F., Yonezawa, T., Kimura, T. (1999) Increased expression of multidrug resistance of P-glycoprotein on Th1 cells correlates with drug resistance in rheumatoid arthritis. Arthritis Rheum. 42, 2014-2015. (Pubitemid 30257775)
173. Agarwal, V., Mittal, S. K., Misra, R. (2009) Expression of multidrug resistance-1 protein correlates with disease activity rather than the refractoriness to methotrexate therapy in rheumatoid arthritis. Clin. Rheumatol. 28, 427-433.
174. Jorgensen, C., Sun, R., Rossi, J. F., Costes, J., Richard, D., Bologna, C., Sany, J. (1995) Expression of a multidrug resistance gene in human rheumatoid synovium. Rheumatol. Int. 15, 83-86.
175. Oerlemans, R., Dijkmans, B. A. C., van der Heijden, J. W., Lems, W. F., Reurs, A., Scheffer, G. L., Scheper, R. J., Jansen, G. (2005) Differential expression of multidrug resistance-related proteins on monocyte-derived macrophages from rheumatoid arthritis patients. Arthritis Res. Ther. 7, S32.
176. Richaud-Patin, Y., Vega-Boada, F., Vidaller, A., Llorente, L. (2004) Multidrug resistance-1 (MDR-1) in autoimmune disorders IV. P-glycoprotein overfunction in lymphocytes from myasthenia gravis patients. Biomed. Pharmacother. 58, 320-324. (Pubitemid 38759731)
177. Ruiz-Soto, R., Richaud-Patin, Y., Lopez-Karpovitch, X., Llorente, L. (2003) Multidrug resistance-1 (MDR-1) in autoimmune disorders III: increased P-glycoprotein activity in lymphocytes from immune thrombocytopenic purpura patients. Exp. Hematol. 31, 483-487. (Pubitemid 36793954)
178. Levy, A. S., Cunningham-Rundles, S., Mazza, B., Simm, M., Gorlick, R., Bussel, J. (2002) High P-glycoprotein-mediated export observed in patients with a history of idiopathic thrombocytopenic purpura. Br. J. Haematol. 118, 836-838. (Pubitemid 35012024)
179. Duffy, C. P., Elliott, C. J., O'Connor, R. A., Heenan, M. M., Coyle, S., Cleary, I. M., Kavanagh, K., Verhaegen, S., O'Loughlin, C. M., NicAmhlaoibh, R., Clynes, M. (1998) Enhancement of chemotherapeutic drug toxicity to human tumor cells in vitro by a subset of non-steroidal antiinflammatory drugs (NSAIDs). Eur. J. Cancer 34, 1250-1259. (Pubitemid 28342118)
180. Le Maux Chansac, B., Moretta, A., Vergnon, I., Opolon, P., Lecluse, Y., Grunenwald, D., Kubin, M., Soria, J. C., Chouaib, S., Mami-Chouaib, F. (2005) NK cells infiltrating a MHC class I-deficient lung adenocarcinoma display impaired cytotoxic activity toward autologous tumor cells associated with altered NK cell-triggering receptors. J. Immunol. 175, 5790-5798. (Pubitemid 41508063)